Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer.

OBJECTIVE The purpose of this article is to study relationships between MRI-based prostate volume and volume-adjusted serum prostate-specific antigen (PSA) concentration estimates and prostate cancer Gleason score. MATERIALS AND METHODS The study included 61 patients with prostate cancer (average age, 63.3 years; range 52-75 years) who underwent MRI before prostatectomy. A semiautomated and MRI-based technique was used to estimate total and central gland prostate volumes, central gland volume fraction (central gland volume divided by total prostate volume), PSA density (PSAD; PSA divided by total prostate volume), and PSAD for the central gland (PSA divided by central gland volume). These MRI-based volume and volume-adjusted PSA estimates were compared with prostatectomy specimen weight and Gleason score by using Pearson (r) or Spearman (ρ) correlation coefficients. RESULTS The estimated total prostate volume showed a high correlation with reference standard volume (r = 0.94). Of the 61 patients, eight (13.1%) had a Gleason score of 6, 40 (65.6%) had a Gleason score of 7, seven (11.5%) had a Gleason score of 8, and six (9.8%) had a Gleason score of 9 for prostate cancer. The Gleason score was significantly correlated with central gland volume fraction (ρ = -0.42; p = 0.0007), PSAD (ρ = 0.46; p = 0.0002), and PSAD for the central gland (ρ = 0.55; p = 0.00001). CONCLUSION Central gland volume fraction, PSAD, and PSAD for the central gland estimated from MRI examinations show a modest but significant correlation with Gleason score and have the potential to contribute to personalized risk assessment for significant prostate cancer.

[1]  A. Tewari,et al.  Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients. , 1995, Urology.

[2]  L Axel,et al.  Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. , 1989, Radiology.

[3]  Shu Liao,et al.  Sparse Patch Based Prostate Segmentation in CT Images , 2012, MICCAI.

[4]  S B Malkowicz,et al.  Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .

[5]  Chang Wook Jeong,et al.  Comparison of Prostate Volume Measured by Transrectal Ultrasonography and MRI with the Actual Prostate Volume Measured after Radical Prostatectomy , 2005, Urologia Internationalis.

[6]  Jae Seok Lee,et al.  Transrectal Ultrasound versus Magnetic Resonance Imaging in the Estimation of Prostate Volume as Compared with Radical Prostatectomy Specimens , 2007, Urologia Internationalis.

[7]  N. Konishi,et al.  Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels , 2007, Prostate Cancer and Prostatic Diseases.

[8]  P. Malone,et al.  Prostate , 1995 .

[9]  S. Kaplan,et al.  Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. , 1995, The Journal of urology.

[10]  M. Benson,et al.  The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. , 1992, The Journal of urology.

[11]  Peter C Albertsen,et al.  Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. , 2009, Journal of the National Cancer Institute.

[12]  Douglas Skarecky,et al.  Prostate volume estimation using the ellipsoid formula consistently underestimates actual gland size. , 2008, The Journal of urology.

[13]  Kazuto Ito,et al.  Diagnostic significance of PSA density adjusted by transition zone volume in males with PSA levels between 2 and 4ng/ml. , 2004, European urology.

[14]  D. Moon,et al.  Prostate‐specific antigen adjusted for the transition zone volume as a second screening test: A prospective study of 248 cases , 2006, International journal of urology : official journal of the Japanese Urological Association.

[15]  C. Catton,et al.  Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  M. Graefen,et al.  Biochemical recurrence following radical prostatectomy: A comparison between prostate cancers located in different anatomical zones , 2003, The Prostate.

[17]  T. Stamey,et al.  Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. , 1993, The Journal of urology.

[18]  H. Hricak,et al.  MR imaging of the prostate gland: normal anatomy. , 1987, AJR. American journal of roentgenology.

[19]  A W Partin,et al.  Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.

[20]  W. Cooner,et al.  Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. , 1994, Urology.

[21]  P. Walsh,et al.  Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The Journal of urology.

[22]  K. Sugimura,et al.  Benign prostatic hyperplasia: value of MR imaging for determining histologic type. , 1994, Radiology.

[23]  J. McNeal,et al.  MR Depiction of Zonal Anatomy of the Prostate at 1.5 T , 1986, Journal of computer assisted tomography.

[24]  C C Schulman,et al.  Prostate specific antigen density of the transition zone for early detection of prostate cancer. , 1998, The Journal of urology.

[25]  D. Siders,et al.  Prostate cancer: Transrectal ultrasound and pathology comparison. A preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer , 1991, Cancer.

[26]  M. Varma,et al.  The weight of the prostate gland is an excellent surrogate for gland volume , 2010, Histopathology.

[27]  C. Metz,et al.  "Proper" Binormal ROC Curves: Theory and Maximum-Likelihood Estimation. , 1999, Journal of mathematical psychology.

[28]  H. Ringertz,et al.  Assessment of Prostatic Size with Computed Tomography , 1982, Acta radiologica: diagnosis.

[29]  J. Lewin,et al.  Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. , 1989, Radiology.

[30]  Aytekin Oto,et al.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.

[31]  J. Heverhagen,et al.  Assessing Prostate Volume by Magnetic Resonance Imaging: A Comparison of Different Measurement Approaches for Organ Volume Analysis , 2005, Investigative radiology.

[32]  E. Kikuchi,et al.  Predicting the probability of significant prostate cancer in Japanese men with serum prostate‐specific antigen less than 10 ng/mL: Development of a novel pre‐biopsy nomogram , 2010, International journal of urology : official journal of the Japanese Urological Association.

[33]  Anant Madabhushi,et al.  Automated computer-derived prostate volumes from MR imaging data: comparison with radiologist-derived MR imaging and pathologic specimen volumes. , 2012, Radiology.

[34]  A. Zlotta,et al.  Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective mu , 2002, Urology.

[35]  A. D'Amico,et al.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Y. Choi,et al.  Interobserver variability of transrectal ultrasound for prostate volume measurement according to volume and observer experience. , 2009, AJR. American journal of roentgenology.

[37]  J. McNeal,et al.  Regional morphology and pathology of the prostate. , 1968, American journal of clinical pathology.

[38]  S. Greenfield,et al.  Overtreatment of men with low‐risk prostate cancer and significant comorbidity , 2011, Cancer.

[39]  A. Zlotta,et al.  Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml. , 1998, The Journal of urology.

[40]  M. Kattan,et al.  Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2006, Journal of the National Cancer Institute.

[41]  Hartwig Huland,et al.  Prostate cancers in the transition zone: Part 2; clinical aspects , 2004, BJU international.

[42]  T. Stamey,et al.  An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. , 2000, The Journal of urology.